WallStreetZenWallStreetZen

NASDAQ: ZVSA
Zyversa Therapeutics Inc Stock

$2.10-0.05 (-2.33%)
Updated Jan 27, 2023
ZVSA Price
$2.10
Fair Value Price
N/A
Market Cap
$21.06M
52 Week Low
$1.38
52 Week High
$25.00
P/E
-7x
P/B
-5.06x
P/S
N/A
PEG
N/A
Dividend Yield
N/A
Revenue
$0.00
Earnings
-$2.03M
Gross Margin
N/A
Operating Margin
N/A
Profit Margin
N/A
Debt to Equity
-1.2
Operating Cash Flow
-$1M
Beta
0.53
Next Earnings
N/A
Ex-Dividend
N/A
Next Dividend
N/A

ZVSA Overview

Larkspur Health Acquisition Corporation is a "blank check" company formed to effect mergers, stock purchases, or similar combinations with one or more businesses. It targets the biotech sector in the U.S. Larkspur Health Acquisition was incorporated in 2021 and is headquartered in Bridgewater, NJ.

Zen Score

Industry Average (28)
You've viewed Zen Score for 10/10 free stocks. Upgrade to Premium to see how ZVSA scored across 33 valuation, financial, forecast, performance, and dividend due diligence checks.

Due Diligence Checks

ZVSA is unprofitable, so we are unable to calculate its intrinsic value according to an updated version of Benjamin Graham's Formula from "The Intelligent Investor"
Below Benjamin Graham Formula Value Valuation
ZVSA is unprofitable, so we are unable to assess its PEG ratio
PEG Value Valuation
ZVSA's cash and short-term investments... subscribe to Premium to read more.
Interest Coverage Financials
There are 30 more ZVSA due diligence checks available for Premium users.

Be the first to know about important ZVSA news, forecast changes, insider trades & much more!

ZVSA News

Valuation

ZVSA fair value

Fair Value of ZVSA stock based on Discounted Cash Flow (DCF)
Price
$2.10
Fair Value
$9.72
Undervalued by
78.39%
ZVSA is unprofitable, so we... subscribe to Premium to read more.
Below Benjamin Graham Formula Value Valuation

ZVSA price to earnings (PE)

For valuing profitable companies with steady earnings
Company
-7x
Industry
12.89x
Market
23.59x

ZVSA price to book (PB)

For valuing companies that are loss-making or have lots of physical asset
Company
-5.06x
Industry
5.18x

ZVSA's financial health

Profit margin

Revenue
$0.0
Net Income
-$679.1k
Profit Margin
0%
ZVSA's cash and short-term investments... subscribe to Premium to read more.
Interest Coverage Financials

Assets to liabilities

Assets
$79.4M
Liabilities
$5.0M
Debt to equity
-1.2
ZVSA's short-term liabilities ($1.63M) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
ZVSA's long-term liabilities ($3.38M) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
ZVSA's debt relative to shareholder... subscribe to Premium to read more.
Shrinking Debt Financials
ZVSA's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials

Cash flow

Operating
-$126.5k
Investing
$0.0
Financing
$0.0
ZVSA's cash and short-term investments... subscribe to Premium to read more.
Debt Coverage Financials

ZVSA vs Biotech Stocks

TickerMarket Cap1d %P/EP/B
ZVSA$21.06M-2.33%-7.00x-5.06x
ANGN$21.08M0.00%-1.40x0.42x
FBRX$21.21M0.00%-1.31x0.50x
EFTR$21.32M+5.60%0.42x1.84x
SNGX$20.75M+1.69%-1.37x20.11x

Zyversa Therapeutics Stock FAQ

What is Zyversa Therapeutics's quote symbol?

NASDAQ: ZVSA) Zyversa Therapeutics trades on the NASDAQ under the ticker symbol ZVSA. Zyversa Therapeutics stock quotes can also be displayed as NASDAQ: ZVSA.

If you're new to stock investing, here's how to buy Zyversa Therapeutics stock.

What is the 52 week high and low for Zyversa Therapeutics (NASDAQ: ZVSA)?

(NASDAQ: ZVSA) Zyversa Therapeutics's 52-week high was $25.00, and its 52-week low was $1.38. It is currently -91.6% from its 52-week high and 52.17% from its 52-week low.

How much is Zyversa Therapeutics stock worth today?

(NASDAQ: ZVSA) Zyversa Therapeutics currently has 10,029,221 outstanding shares. With Zyversa Therapeutics stock trading at $2.10 per share, the total value of Zyversa Therapeutics stock (market capitalization) is $21.06M.

Zyversa Therapeutics stock was originally listed at a price of $9.98 in Dec 21, 2021. If you had invested in Zyversa Therapeutics stock at $9.98, your return over the last 1 years would have been -78.96%, for an annualized return of -78.96% (not including any dividends or dividend reinvestments).

How much is Zyversa Therapeutics's stock price per share?

(NASDAQ: ZVSA) Zyversa Therapeutics stock price per share is $2.10 today (as of Jan 27, 2023).

What is Zyversa Therapeutics's Market Cap?

(NASDAQ: ZVSA) Zyversa Therapeutics's market cap is $21.06M, as of Jan 29, 2023.

Market cap (market capitalization) is the total market value of a publicly traded company's outstanding shares.

Zyversa Therapeutics's market cap is calculated by multiplying ZVSA's current stock price of $2.10 by ZVSA's total outstanding shares of 10,029,221.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.